Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.33116 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.23844 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.24007 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.13877 | 50 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.15298 | 50 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.38915 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.39515 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.21583 | 51 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.17879 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.20271 | 51 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.23531 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16735 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.25396 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.23639 | 51 |